These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1148534

  • 1. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A, Jenner P, Marsden CD.
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract] [Full Text] [Related]

  • 2. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase.
    Dolphin A, Jenner P, Marsden CD.
    Eur J Pharmacol; 1976 Jan; 35(1):135-44. PubMed ID: 1253815
    [Abstract] [Full Text] [Related]

  • 3. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC, Jenner P, Marsden CD.
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proceedings: Influence of H44/68 and FLA63 on central catecholamines and motor activity under light and darkness.
    Lemmer B, Berger T.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Jun; 287 Suppl():R13. PubMed ID: 238144
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J, Lewander T.
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract] [Full Text] [Related]

  • 8. The irritant properties of dopamine-beta-hydroxylase inhibitors in relation to their effects on L-dopa-induced locomotor activity.
    Dolphin A, Elliott PN, Jenner P.
    J Pharm Pharmacol; 1976 Oct; 28(10):782-5. PubMed ID: 10378
    [No Abstract] [Full Text] [Related]

  • 9. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF, Buckley JP.
    J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
    [No Abstract] [Full Text] [Related]

  • 10. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse.
    Sharkawi M.
    J Pharm Pharmacol; 1979 May; 31(5):340-1. PubMed ID: 37309
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological and metabolic interactions between ethanol and the dopamine-beta-hydroxylase inhibitor FLA 63 in mice.
    Sharkawi M.
    Neuropharmacology; 1980 Mar; 19(3):277-80. PubMed ID: 6999373
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of some dopamine-beta-hydroxylase inhibitors on the control mechanisms of the estrous cycle in rats.
    Kun I.
    Endocrinologie; 1978 Mar; 16(4):263-8. PubMed ID: 569899
    [Abstract] [Full Text] [Related]

  • 16. Effects of dopamine-beta-hydroxylase inhibitors FLA-57 and FLA-63 on ethanol metabolism and aldehyde dehydrogenase activity in rats.
    Tottmar O, Hellström E, Holmberg K, Lindros KO.
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):198-202. PubMed ID: 7136724
    [Abstract] [Full Text] [Related]

  • 17. Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice.
    Ross SB, Ogren SO.
    J Pharm Pharmacol; 1976 Jul; 28(7):590-2. PubMed ID: 8618
    [No Abstract] [Full Text] [Related]

  • 18. Some characteristics of amnesia induced by FLA-63 an inhibitor of dopamine beta hydroxylase.
    Botwinick CY, Quartermain D, Freedman LS, Hallock MF.
    Pharmacol Biochem Behav; 1977 May; 6(5):487-91. PubMed ID: 19771
    [Abstract] [Full Text] [Related]

  • 19. The involvement of the catecholaminergic system in physostigmine-induced hyperactivity in rats.
    Egbe PC.
    Arzneimittelforschung; 1982 May; 32(1):27-9. PubMed ID: 6460507
    [Abstract] [Full Text] [Related]

  • 20. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z, Levitan DE, Lindros KO.
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.